王守豐，男，醫學博士，畢業于南京大學。專業：骨與軟組織腫瘤。(1)/4th Orthopaedic and Traumatologic Clinic prevalently Oncologic, Rizzoli Orthopaedic Institute, Bologna, Italy.(2)/Department of Musculoskeletal oncology and rehabilitaion, National Cancer Center, Tokyo, Japan,訪問學者。南京大學醫學院、南京醫科大學碩士研究生導師、副教授。南京市第九批中青年行業技術學科帶頭人，獲得南京市科技進步3等獎和南京市科技進步1等獎，江蘇省“十二五”醫學重點人才，“六大人才高峰”培養對象。江蘇省“333高層次人才培養工程”培養對象，中國抗癌協會肉瘤專業委員會委員，中國抗癌協會肉瘤專業委員會全國青年委員，中華醫學會骨質疏松與骨礦鹽分會全國青年委員，中國抗癌協會肉瘤專業委員會脊柱腫瘤學組委員，江蘇省骨科學分會骨腫瘤學組委員、副組長，中國腫瘤外科雜志、中國矯形外科雜志編委等。 發表論文及著作： 37.Xu leilei, Xia Chao, Sun Qi, Sheng Fei, Xiong Jin, Wang Shoufeng. Variations of Fasl and ABCC5 are predictive of outcome after chemotherapy based treatment in osteosarcoma. Journal of Bone Oncology, 2018,12:44-48. 36.文立,王守豐.四肢骨巨細胞瘤伴病理性骨折的治療進展.中國腫瘤外科雜志.2018，10（2）：72-76. 35.Leilei Xu 1, Chao Xia, Fei Sheng, Qi Sun, Jin Xiong and Shoufeng Wang. CEP55 promotes the proliferation and invasion of tumour cells via the AKT signalling pathway in osteosarcoma. Carcinogenesis, 2018, Vol. 39, No. 4, 623–631. 34.Leilei Xu, Jin Zhou, Zhou Wang, Jin Xiong, Yong Qiu, Shoufeng Wang. Reconstruction of bone defect with allograft and retrograde intramedullary nail for distal tibia osteosarcoma. Foot and Ankle Surgery, 2018, 24: 149-153. 1.Leilei, Xu Xinhua Li,Zhou Wang, Jin Xiong and Shoufeng Wang.Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system. Health and Quality of Life Outcomes (2017) 15:107 2.Leilei Xu, Minghui Sun, Weixiang Sun, Xiaodong Qin, Zezhang Zhu and Shoufeng Wang.Cross-cultural adaptation and validation of the Chinese version of Toronto Extremity Salvage Score for patients with extremity sarcoma. SpringerPlus,2016, 5:1118 .(Correspondence) 3.Zitao Zhang, Jin Xiong, Shoufeng Wang, Yong Qiu.Associations between VEGF polymorphisms and the risk and prognosis of osteosarcoma: a systematic review and meta-analysis.Int J Clin Exp Med 2016;9(2):515-524 4.Wang Shoufeng, Qiu Yong, Liu Wen

骨與軟組織腫瘤的診斷及治療,惡性骨與軟組織腫瘤的化療及保肢治療,骨轉移癌的外科治療及綜合治療